Dana Gelly

Dana Gelly is a seasoned sales professional with extensive experience in the pharmaceutical and medical device industries. Currently serving as Regional Sales Director at UCB since August 2024, Dana previously held a prominent role as Director of Sales at Organogenesis from January 2010 to August 2024, consistently surpassing sales targets across 15 states while managing a team of approximately 40. Dana's career features progressive leadership positions, such as Regional Sales Manager at Organogenesis, where Dana oversaw $15 million in annual revenue, and earlier roles at Novo Nordisk A/S and Cephalon, focusing on sales, education, and strategic product launches. Dana began the career at HI-Eisai Pharmaceutical, Inc. as a Senior Medical Sales Specialist with a focus on rare diseases. Dana holds a degree from SUNY Geneseo.